ananthvikas retweeted
Replying to @ISAC_CYTO
#FlowTCS2026 is just round the corner. We look forward to welcoming over 350 avid #flowcytometry colleagues from across India and abroad to this academic extravaganza. If you are there, do come and say "hi"! @drkunalsehgal @PrashantTembha1 @DrArunCMC @ananthvikas @HandooAnil
ananthvikas retweeted
Replying to @ICCS_updates
#FlowTCS2026 is just round the corner. We look forward to welcoming over 350 avid #flowcytometry colleagues from across India and abroad to this academic extravaganza. If you are there, do come and say "hi"! @drkunalsehgal @PrashantTembha1 @DrArunCMC @ananthvikas @HandooAnil
ananthvikas retweeted
#FlowTCS2026 is just round the corner. We look forward to welcoming over 350 avid #flowcytometry colleagues from across India and abroad to this academic extravaganza. If you are there, do come and say "hi"! @drkunalsehgal @PrashantTembha1 @DrArunCMC @ananthvikas @HandooAnil
ananthvikas retweeted
Excited to share Consensus recommendations for technical aspects of Flow Cytometric BALL MRD. A collective efforts of many experts in the field. @CytometryIndia @News_ICCS @ICCS_Education @EsccaOfficial @LabOrfao @pho_india @HCC_HemeCancer @drkunalsehgal @sindhucherian
ananthvikas retweeted
Stuck on a tough leukemia/lymphoma #flowcytometry case? Bring it to the experts.
TCS online session on challenging case interpretation: Ask the Experts!
🗓 8 Aug, 12 noon IST · Free registration
forms.gle/a8SEBRX13rm6Syxq9
@drkunalsehgal @PrashantTembha1 @LakshmiKoulmane @DrArunCMC
ananthvikas retweeted
Demystifying Anemia - An effort in spreading awareness and working towards the goal of “Anemia Mukt Bharat”
@MoHFW_INDIA @mybmcwardKW @Blues_Blue34 @ananthvikas @nihardesai89 @Neuberg_Diag
Anemia remains one of India’s most pressing public health challenges, ranking as the second leading cause of maternal mortality and affecting more than half of the country’s women and children.
Watch the full video here: zurl.co/5pvZ5
ananthvikas retweeted
I'm working on a teaching presentation on Hodgkin's lymphoma.
Picture below contains HRS-like cells from 9 different cases.
Which ones are classical Hodgkin's lymphoma and which ones are something else?
#hemepath #pathtwitter #pathology
ananthvikas retweeted
Equity in cancer diagnosis is not just a technical challenge but a moral imperative. Cancer is not merely a disease of the affluent; it is a leading cause of death worldwide.
bmjoncology.bmj.com/content/…
A thought-provoking editorial with a very clear message - A must-read if you are involved in cancer diagnostics or care in any way.
The WHO has long upheld health equity as a guiding principle. Yet this principle is not fully realised in its most influential product in oncology: the WHO Classification of Tumours.
@Vik_deshpandeMD @BenMazer and Sanjay Pai
ananthvikas retweeted
Some lovely group photos from the fantastic B MRD guideines meeting. Great initiative by @CytometryIndia team and big thanks to @LabOrfao for his whole hearted support for this meeting @PrashantTembha1
ananthvikas retweeted
National B MRD consensus guidelines by @CytometryIndia group led by @PrashantTembha1 and TCS team - the journey begins !
Starting day 1 of the landmark B-ALL consensus meeting with right earnest at @ACTREC_TMC. @CytometryIndia
The BMRD #flowcytometry workshop at @ACTREC_TMC is off to a great start with amazing talks from @P_G_Subramanian , @LabOrfao and @RajpalSweta . Lot of insightful discussions and revelations, in a packed hall! @CytometryIndia
ananthvikas retweeted
Did you know… Not all CD38 directed targeted therapy has the same impact on flow cytometry studies. To learn more, see this recent report in the @BrJHaem brought to you by @AfshinShameli .
doi.org/10.1111/bjh.20218
ananthvikas retweeted
Excellent article and image explaining the impact of Anti CD38 monoclonal antibodies on flow Cytometry testing. Knowing the clone you use in practice and clinical scenario becomes even more vital @CytometryIndia @PrashantTembha1 @ananthvikas
Did you know… Not all CD38 directed targeted therapy has the same impact on flow cytometry studies. To learn more, see this recent report in the @BrJHaem brought to you by @AfshinShameli .
doi.org/10.1111/bjh.20218
ananthvikas retweeted
"Global Oncology Inequities: The Cost of ‘Not Otherwise Specified’ in WHO Tumor Classifications 🧵" A tweetorial


































